Indication
Constella is indicated for the symptomatic treatment of moderate to severe irritable-bowel syndrome with constipation (IBS-C) in adults.
In other countries
The same active substances on other registers, the same brand first.
National listings
The national registers that list this EU medicine.
- ConstellaCanada · 145 MCG · Capsule · Abbvie CorporationSame brand
- ConstellaCanada · 72 MCG · Capsule · Abbvie CorporationSame brand
- ConstellaCanada · 290 MCG · Capsule · Abbvie CorporationSame brand
- Constella 290 microgramos capsulas durasSpain · 0,290 mg · cápsula dura · Abbvie Deutschland Gmbh & Co. KgSame brand